Full metadata record

DC Field Value Language
dc.contributor.authorAljohani, Hashim M.-
dc.contributor.authorAittaleb, Mohamed-
dc.contributor.authorBahassi, El Mustapha-
dc.contributor.authorLee, So Ha-
dc.contributor.authorPark, Byung Sun-
dc.date.accessioned2024-01-12T06:13:00Z-
dc.date.available2024-01-12T06:13:00Z-
dc.date.created2022-02-28-
dc.date.issued2017-10-
dc.identifier.issn1535-7163-
dc.identifier.urihttps://pubs.kist.re.kr/handle/201004/79473-
dc.languageEnglish-
dc.publisherAMER ASSOC CANCER RESEARCH-
dc.titlePreclinical evaluation of a new ROS1 inhibitor to overcome resistance to EGFR therapy in glioblastoma-
dc.typeConference-
dc.identifier.doi10.1158/1535-7163.TARG-17-A141-
dc.description.journalClass1-
dc.identifier.bibliographicCitation2017 AACR-NCI-EORTC International Conference-
dc.citation.title2017 AACR-NCI-EORTC International Conference-
dc.citation.conferencePlaceUS-
dc.citation.conferencePlacePhiladelphia, PA-
dc.citation.conferenceDate2017-10-26-
dc.relation.isPartOfMOLECULAR CANCER THERAPEUTICS-
dc.identifier.wosid000590008800130-
Appears in Collections:
KIST Conference Paper > 2017
Files in This Item:
There are no files associated with this item.
Export
RIS (EndNote)
XLS (Excel)
XML

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

BROWSE